Drug-induced osteoporosis: Beyond glucocorticoids

被引：14
|
作者：
Briot K. [1 ]
Roux C. [1 ]
机构：
[1] Department of Rheumatology, Cochin Hospital, 75014 Paris
来源：
Current Rheumatology Reports | 2008年 / 10卷 / 2期
关键词：
Bone Mineral Density; Osteoporosis; Bone Loss; Fracture Risk; Zoledronic Acid;
D O I：
10.1007/s11926-008-0019-4
中图分类号：
学科分类号：
摘要：
To prevent osteoporotic fractures, it is important to identify patients at high risk of fracture by assessing risk factors such as underlying diseases and drugs. Prior and current use of oral corticosteroids is strongly associated with increased fracture risk, but other medications could be involved and should be assessed as part of the optimal care of patients at risk of osteoporosis. Strong evidence points to gonadotropin-releasing hormone agonists, aromatase inhibitors, and antiepileptic drugs. Further studies are necessary to confirm the deleterious effect of other treatments on bone. Copyright © 2008 by Current Medicine Group LLC.
引用
收藏
页码：102 / 109
页数：7
相关论文
共 50 条
  • [31] DRUG-INDUCED DISEASES - DRUG-INDUCED RESPIRATORY-DISEASE
    GRANT, IWB
    BRITISH MEDICAL JOURNAL, 1979, 1 (6170): : 1070 - 1071
  • [32] DRUG-INDUCED DISEASES - DRUG-INDUCED CARDIOVASCULAR-DISEASE
    BRECKENRIDGE, AM
    BRITISH MEDICAL JOURNAL, 1979, 1 (6166): : 793 - 795
  • [33] Spontaneous reporting of drug-induced osteoporosis or osteomalacia: review of the French pharmacovigilance database
    Salgueiro, M. E.
    Abadie, D.
    Manso, G.
    Bagheri, H.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 106 - 106
  • [34] Drug-induced osteoporosis and mechanisms of bone tissue regeneration through trace elements
    da Costa, Nayara de Souza
    Lima, Luiza Siqueira
    Galiciolli, Maria Eduarda Andrade
    Ribeiro, Deborah Helen Fabiano
    Ribeiro, Milena Mariano
    Garica, Gisele de Paula Julia
    Marcal, Isabela Saragioto
    Silva, Juliana Ferreira da
    Pereira, Meire Ellen
    Oliveira, Claudia Sirlene
    Guiloski, Izonete Cristina
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2024, 84
  • [35] Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
    P. Musette
    M. L. Brandi
    P. Cacoub
    J. M. Kaufman
    R. Rizzoli
    J.-Y. Reginster
    Osteoporosis International, 2010, 21 : 723 - 732
  • [36] DRUG-INDUCED DISEASES - DRUG-INDUCED LIVER-DISEASE
    KEELING, PWN
    THOMPSON, RPH
    BRITISH MEDICAL JOURNAL, 1979, 1 (6169): : 990 - 993
  • [37] Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
    Musette, P.
    Brandi, M. L.
    Cacoub, P.
    Kaufman, J. M.
    Rizzoli, R.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (05) : 723 - 732
  • [38] Drug-Induced Polyneuropathies Beyond Chemotherapeutic Agents and Anti-Infectives
    Achenbach, Pascal
    Block, Frank
    Dafotakis, Manuel
    KLINISCHE NEUROPHYSIOLOGIE, 2022, 53 (03) : 174 - 187
  • [39] Osteoporosis induced by glucocorticoids: what's new?
    Aguado Acin, Maria Pilar
    REUMATOLOGIA CLINICA, 2007, 3 : 3 - 8
  • [40] OSTEOPOROSIS INDUCED BY GLUCOCORTICOIDS IN PEDIATRICS Authors'Reply
    Brunetto, Oscar
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2024, 122 (02):
12345